Active options: PFE MSTR PLTR NIO MSFT OXY DJT RIOT BA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Pfizer (PFE) PT Raised to $31 at CFRA
October 7, 2024 2:55 PM EDTCFRA analyst Sel Hardy raised the price target on Pfizer (NYSE: PFE) to $31.00 (from $30.00) while maintaining a Hold rating.
The analyst comments "We raise our target price to $31 from $30, 10.9x our 2025 EPS, below PFEs historical forward P/E average. We lift our 2024 EPS... More



